Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Albumin-Bound Paclitaxel × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

OTHER 139 INDUSTRY 57 NETWORK 5 OTHER_GOV 3 NIH 3 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Gynecologic 1 Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

S 1 (combination) 13 Paclitaxel 10 Oxaliplatin 10 Capecitabine 9 Irinotecan 6 Cisplatin 6 titanium silicide 4 sintilimab 3 nimotuzumab 3 nedaplatin 3 TP protocol 3 HMPL-013 3 Fluorouracil 3 Bevacizumab 3 toripalimab 2 raltitrexed 2 Trastuzumab 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Adjuvant 2 Radiosurgery 2 Radiation 2 Leucovorin 2 Chemotherapy, Adjuvant 2 pegylated granulocyte colony-stimulating factor 1 endostar protein 1 durvalumab 1 camrelizumab 1 apatinib 1 Thalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01980810 2016-06-14

GC-A-003

ChineseAMS

Phase 2 Terminated

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡